Cargando…
Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases
BACKGROUND: Tertiary lymphoid structures (TLSs) have been proposed to assess the prognosis of patients with cancer. Here, we investigated the prognostic value and relevant mechanisms of TLSs in colorectal cancer liver metastases (CRCLM). METHODS: 603 patients with CRCLM treated by surgical resection...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923349/ https://www.ncbi.nlm.nih.gov/pubmed/36759015 http://dx.doi.org/10.1136/jitc-2022-006425 |
_version_ | 1784887719034355712 |
---|---|
author | Zhang, Chong Wang, Xiang-Yu Zuo, Jie-Liang Wang, Xue-Fu Feng, Xiao-Wen Zhang, Bo Li, Yi-Tong Yi, Chen-He Zhang, Peng Ma, Xiao-Chen Chen, Zhen-Mei Ma, Yue Han, Jia-Hao Tao, Bao-Rui Zhang, Rui Wang, Tian-Qi Tong, Li Gu, Wang Wang, Si-Yu Zheng, Xiao-Fei Yuan, Wen-Kang Kan, Zi-Jie Fan, Jie Hu, Xiang-Yang Li, Jun Zhang, Chao Chen, Jin-Hong |
author_facet | Zhang, Chong Wang, Xiang-Yu Zuo, Jie-Liang Wang, Xue-Fu Feng, Xiao-Wen Zhang, Bo Li, Yi-Tong Yi, Chen-He Zhang, Peng Ma, Xiao-Chen Chen, Zhen-Mei Ma, Yue Han, Jia-Hao Tao, Bao-Rui Zhang, Rui Wang, Tian-Qi Tong, Li Gu, Wang Wang, Si-Yu Zheng, Xiao-Fei Yuan, Wen-Kang Kan, Zi-Jie Fan, Jie Hu, Xiang-Yang Li, Jun Zhang, Chao Chen, Jin-Hong |
author_sort | Zhang, Chong |
collection | PubMed |
description | BACKGROUND: Tertiary lymphoid structures (TLSs) have been proposed to assess the prognosis of patients with cancer. Here, we investigated the prognostic value and relevant mechanisms of TLSs in colorectal cancer liver metastases (CRCLM). METHODS: 603 patients with CRCLM treated by surgical resection from three cancer centers were included. The TLSs were categorized according to their anatomic subregions and quantified, and a TLS scoring system was established for intratumor region (T score) and peritumor region (P score). Differences in relapse-free survival (RFS) and overall survival (OS) between groups were determined. Multiplex immunohistochemical staining (mIHC) was used to determine the cellular composition of TLSs in 40 CRCLM patients. RESULTS: T score positively correlated with superior prognosis, while P score negatively associated with poor survival (all p<0.05). Meanwhile, T score was positively associated with specific mutation subtype of KRAS. Furthermore, TLSs enrichment gene expression was significantly associated with survival and transcriptomic subtypes of CRCLM. Subsequently, mIHC showed that the densities of Treg cells, M2 macrophages and Tfh cells were significantly higher in intratumor TLSs than in peritumor TLSs (p=0.029, p=0.047 and p=0.041, respectively), and the frequencies of Treg cells and M2 macrophages were positively correlated with P score, while the frequencies of Tfh cells were positively associated with T scores in intratumor TLSs (all p<0.05). Next, based on the distribution and abundance of TLSs, an Immune Score combining T score and P score was established which categorized CRCLM patients into four immune classes with different prognosis (all p<0.05). Among them, patients with higher immune class have more favorable prognoses. The C-index of Immune Class for RFS and OS was higher than Clinical Risk Score statistically. These results were also confirmed by the other two validation cohorts. CONCLUSIONS: The distribution and abundance of TLSs is significantly associated with RFS and OS of CRCLM patients, and a novel immune class was proposed for predicting the prognosis of CRCLM patients. |
format | Online Article Text |
id | pubmed-9923349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-99233492023-02-14 Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases Zhang, Chong Wang, Xiang-Yu Zuo, Jie-Liang Wang, Xue-Fu Feng, Xiao-Wen Zhang, Bo Li, Yi-Tong Yi, Chen-He Zhang, Peng Ma, Xiao-Chen Chen, Zhen-Mei Ma, Yue Han, Jia-Hao Tao, Bao-Rui Zhang, Rui Wang, Tian-Qi Tong, Li Gu, Wang Wang, Si-Yu Zheng, Xiao-Fei Yuan, Wen-Kang Kan, Zi-Jie Fan, Jie Hu, Xiang-Yang Li, Jun Zhang, Chao Chen, Jin-Hong J Immunother Cancer Immunotherapy Biomarkers BACKGROUND: Tertiary lymphoid structures (TLSs) have been proposed to assess the prognosis of patients with cancer. Here, we investigated the prognostic value and relevant mechanisms of TLSs in colorectal cancer liver metastases (CRCLM). METHODS: 603 patients with CRCLM treated by surgical resection from three cancer centers were included. The TLSs were categorized according to their anatomic subregions and quantified, and a TLS scoring system was established for intratumor region (T score) and peritumor region (P score). Differences in relapse-free survival (RFS) and overall survival (OS) between groups were determined. Multiplex immunohistochemical staining (mIHC) was used to determine the cellular composition of TLSs in 40 CRCLM patients. RESULTS: T score positively correlated with superior prognosis, while P score negatively associated with poor survival (all p<0.05). Meanwhile, T score was positively associated with specific mutation subtype of KRAS. Furthermore, TLSs enrichment gene expression was significantly associated with survival and transcriptomic subtypes of CRCLM. Subsequently, mIHC showed that the densities of Treg cells, M2 macrophages and Tfh cells were significantly higher in intratumor TLSs than in peritumor TLSs (p=0.029, p=0.047 and p=0.041, respectively), and the frequencies of Treg cells and M2 macrophages were positively correlated with P score, while the frequencies of Tfh cells were positively associated with T scores in intratumor TLSs (all p<0.05). Next, based on the distribution and abundance of TLSs, an Immune Score combining T score and P score was established which categorized CRCLM patients into four immune classes with different prognosis (all p<0.05). Among them, patients with higher immune class have more favorable prognoses. The C-index of Immune Class for RFS and OS was higher than Clinical Risk Score statistically. These results were also confirmed by the other two validation cohorts. CONCLUSIONS: The distribution and abundance of TLSs is significantly associated with RFS and OS of CRCLM patients, and a novel immune class was proposed for predicting the prognosis of CRCLM patients. BMJ Publishing Group 2023-02-09 /pmc/articles/PMC9923349/ /pubmed/36759015 http://dx.doi.org/10.1136/jitc-2022-006425 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Immunotherapy Biomarkers Zhang, Chong Wang, Xiang-Yu Zuo, Jie-Liang Wang, Xue-Fu Feng, Xiao-Wen Zhang, Bo Li, Yi-Tong Yi, Chen-He Zhang, Peng Ma, Xiao-Chen Chen, Zhen-Mei Ma, Yue Han, Jia-Hao Tao, Bao-Rui Zhang, Rui Wang, Tian-Qi Tong, Li Gu, Wang Wang, Si-Yu Zheng, Xiao-Fei Yuan, Wen-Kang Kan, Zi-Jie Fan, Jie Hu, Xiang-Yang Li, Jun Zhang, Chao Chen, Jin-Hong Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases |
title | Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases |
title_full | Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases |
title_fullStr | Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases |
title_full_unstemmed | Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases |
title_short | Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases |
title_sort | localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases |
topic | Immunotherapy Biomarkers |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9923349/ https://www.ncbi.nlm.nih.gov/pubmed/36759015 http://dx.doi.org/10.1136/jitc-2022-006425 |
work_keys_str_mv | AT zhangchong localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT wangxiangyu localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT zuojieliang localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT wangxuefu localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT fengxiaowen localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT zhangbo localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT liyitong localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT yichenhe localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT zhangpeng localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT maxiaochen localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT chenzhenmei localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT mayue localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT hanjiahao localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT taobaorui localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT zhangrui localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT wangtianqi localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT tongli localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT guwang localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT wangsiyu localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT zhengxiaofei localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT yuanwenkang localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT kanzijie localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT fanjie localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT huxiangyang localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT lijun localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT zhangchao localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases AT chenjinhong localizationanddensityoftertiarylymphoidstructuresassociatewithmolecularsubtypeandclinicaloutcomeincolorectalcancerlivermetastases |